Lindis Biotech, Gmbh V. Amgen Inc.

Case Background

Lindis Biotech, GmbH filed a patent infringement lawsuit against Amgen Inc. for the willful infringement of its patented immunotherapy regimen for cancer treatment. The case was filed in the United States District Court, Delaware (Wilmington). Judge Gregory B. Williams presided over this case. [Case number: 1:22cv35]

Cause

Lindis Biotech, GmbH ("Lindis") developed a patented immunotherapy regimen to address major challenges in cancer treatment. This innovative approach uses bispecific antibodies to target cancer cells, minimize harm to healthy tissue, and prevent excessive immune responses. Unlike traditional therapies like chemotherapy and radiation, which often damage healthy cells and suppress immunity, Lindis